Demenzdiagnose mittels Biomarker – geht das?
Author:
- 17 March 2025
- journal article
- schwerpunkt
- Published by Georg Thieme Verlag KG in neuroreha
- Vol. 17 (01) , 16-24
Abstract
Article published online: 17 March 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, GermanyKeywords
This publication has 32 references indexed in Scilit:
- Plasma pTau217 predicts continuous brain amyloid levels in preclinical and early Alzheimer's diseaseAlzheimer's & Dementia, 2024
- Amyloid‐β PET in Alzheimer's disease: A systematic review and Bayesian meta‐analysisBrain and Behavior, 2022
- Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairmentCochrane Database of Systematic Reviews, 2020
- 18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)Cochrane Database of Systematic Reviews, 2017
- 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)Cochrane Database of Systematic Reviews, 2017
- 18F PET with florbetapir for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Cochrane Database of Systematic Reviews, 2017
- 11C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Cochrane Database of Systematic Reviews, 2014
- Longitudinal assessment of Aβ and cognition in aging and Alzheimer diseaseAnnals of Neurology, 2011
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Current Concepts in Mild Cognitive ImpairmentArchives of Neurology, 2001